Illinois research institutions pulled in $1.26 billion in National Institutes of Health awards in 2025, a 12.4% drop from the year before. The slide stems largely from a retreat in the number of grants handed out as NIH shifted its funding priorities, a change now echoing through Chicago university labs and hospital research programs.
The damage shows up in both total dollars and award counts, with administrators describing the hit as "fewer grants" rather than a haircut for every project. Big local players such as Northwestern and the University of Chicago still ranked among the top recipients even as the pie shrank. According to the Chicago Business Journal, the reshuffling of where NIH is placing its money explains much of the year-over-year drop.
Nationally, an analysis by the Association of American Medical Colleges found that NIH committed nearly $5 billion less in research grants to U.S. institutions in the 12 months ending June 2025 than in the prior year, leaving many labs scrambling for bridge funding and backup plans. The AAMC reports that the disruptions have slowed clinical trials, threatened career-development awards and squeezed training programs. According to AAMC, those gaps carry wide downstream effects for patients, trainees and entire research pipelines.
The turmoil followed federal moves to cap reimbursements for indirect, or overhead, costs and to reprioritize certain research areas, stripping out operating support many campuses had come to rely on. STAT reported that NIH announced a 15% cap on indirect cost reimbursements in February 2025, a shift university leaders warned would squeeze budgets and force hard tradeoffs. Policy analysts say the combination of terminated programs, new caps and shifting priorities explains much of the drop in award counts for states like Illinois.
Local labs feel the squeeze
In Chicago, that policy jargon translated into hiring freezes, delayed equipment purchases and paused subawards, according to internal notices and local reporting. Northwestern posted guidance to faculty describing disrupted cash draws and interim rules that affected payments through late 2025, noting that some federal reimbursements started flowing again in December. Departments that depend on multi-year NIH programs say mid-career investigators and trainees have been especially exposed to the gap.
What this means for jobs and projects
Beyond the topline numbers, experts warn that the shortfall threatens research jobs and timelines for clinical trials and translational projects. The AAMC and other research groups note that NIH awards bankroll thousands of high-paying research positions and underwrite costly clinical trials. When those awards disappear, institutions often scramble to cover salaries and lab overhead. For Chicago-area hospitals and labs, that can mean delayed trials, canceled initiatives or hiring freezes that ripple through the broader biomedical economy.
Legal fight and next steps
States and university coalitions have pushed back in court, and judges have at times blocked parts of the administration’s changes while lawsuits play out. National coverage shows that a temporary restraining order halted implementation of the indirect-cost cap in several states in February 2025, leaving funding flows in limbo for months; see reporting by CNBC. With lawsuits ongoing, Congress watching and agencies issuing new guidance, universities are now eyeing 2026 appropriations and court rulings to see whether anything like a normal grant process returns.
Hoodline previously covered the earlier wave of cancellations and local fallout; see earlier wave of cancellations for background. For now, Illinois scientists say the headline figures, $1.26 billion in awards and a 12.4% year-over-year drop, are a blunt reminder that federal research funding can swing fast, with very real consequences for labs, patients and paychecks across the city.
